Search results
Results From The WOW.Com Content Network
The Ohio Automated Rx Reporting System (OARRS) is Ohio's state Prescription Monitoring Program (PMP) and is controlled by the Ohio State Board of Pharmacy. [1] The law permitting the Board of Pharmacy to create the PMP was signed on March 18, 2005, and became effective January 1, 2006. The OARRS program began operation on October 2, 2006.
Prescription drug monitoring programs, or PDMPs, are an example of one initiative proposed to alleviate effects of the opioid crisis. [1] The programs are designed to restrict prescription drug abuse by limiting a patient's ability to obtain similar prescriptions from multiple providers (i.e. “doctor shopping”) and reducing diversion of controlled substances.
The Gifted Education Program in the Cleveland Metropolitan School District consists of the 'Major Work' Program, currently in grades 2–8, and the Honors and Advanced Placement (AP) Programs in grades 9–12. There are seven PreK-8 Schools, one Grades 2–12 School, and five Grades 9–12 Schools that service gifted identified children.
Apart from measuring the needs, inputs and outcomes of a program, evaluations also monitor the process of a program. [1] According to [2] (p. 171), program process monitoring "is the systematic and continual documentation of [the] key aspects of program performance that assesses whether the program is performing as intended or according to some appropriate standard."
Go: "How to Dance in Ohio," Belasco Theatre, 111 W. 44th St., $48 to $518; 212-239-6200, howtodanceinohiomusical.com. This article originally appeared on Asbury Park Press: How to Dance in Ohio ...
An Ohio teenage girl was convicted of murder on Monday, accused of intentionally killing her boyfriend and his friend by crashing her car into a brick building going 100 mph last year.
Lenzilumab is under development by Humanigen Inc. and was originally designed for the treatment of chronic myelomonocytic leukemia (CMML) and juvenile myelomonocytic leukemia (JMML). [ 14 ] [ 15 ] [ 16 ] In vitro studies on human cells have demonstrated that Lenzilumab can induce sensitivity in myeloid and monocytic cells suggesting the ...
2010 - Medical Mutual selected to run the Ohio High Risk Pool by the Ohio Department of Insurance. [12] The program ended in March 2013. 2011 - Medical Mutual, for the third consecutive year, makes the InformationWeek 500 annual listing of the nation's most innovative users of business technology.